147 related articles for article (PubMed ID: 34926493)
1. Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria.
He P; Zha Y; Liu J; Wang H; He L
Front Med (Lausanne); 2021; 8():737700. PubMed ID: 34926493
[No Abstract] [Full Text] [Related]
2. A Study of Clinical Presentation and Correlative Histopathological Patterns in Renal Parenchymal Disease.
Ganesh K; Nair RR; Seethalekshmy NV; Kurian G; Mathew A; Sreedharan S; Paul Z
Indian J Nephrol; 2018; 28(1):28-34. PubMed ID: 29515298
[TBL] [Abstract][Full Text] [Related]
3. The natural history of the non-nephrotic membranous nephropathy patient.
Hladunewich MA; Troyanov S; Calafati J; Cattran DC;
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1417-22. PubMed ID: 19661220
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
6. Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy.
He P; Yu X; Zha Y; Liu J; Wang H; Huang C; Sun S; He L
Front Med (Lausanne); 2021; 8():704830. PubMed ID: 34957132
[No Abstract] [Full Text] [Related]
7. Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy.
Lee T; Chung Y; Poulton CJ; Derebail VK; Hogan SL; Reich HN; Falk RJ; Nachman PH
Kidney Int Rep; 2020 May; 5(5):706-717. PubMed ID: 32405591
[TBL] [Abstract][Full Text] [Related]
8. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
9. Membranous Nephropathy: Quantifying Remission Duration on Outcome.
Cattran DC; Kim ED; Reich H; Hladunewich M; Kim SJ;
J Am Soc Nephrol; 2017 Mar; 28(3):995-1003. PubMed ID: 27756808
[TBL] [Abstract][Full Text] [Related]
10. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
Laluck BJ; Cattran DC
Am J Kidney Dis; 1999 Jun; 33(6):1026-32. PubMed ID: 10352189
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of native kidney biopsy in low grade, subnephrotic, and nephrotic range proteinuria: A retrospective cohort study.
de Fallois J; Schenk S; Kowald J; Lindner TH; Engesser M; Münch J; Meigen C; Halbritter J
PLoS One; 2022; 17(9):e0273671. PubMed ID: 36054109
[TBL] [Abstract][Full Text] [Related]
13. Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.
Thompson A; Cattran DC; Blank M; Nachman PH
J Am Soc Nephrol; 2015 Dec; 26(12):2930-7. PubMed ID: 26078365
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Serum Complement 4 and Kidney Disease Progression in Idiopathic Membranous Nephropathy: A Multicenter Retrospective Cohort Study.
Liu J; Zha Y; Zhang P; He P; He L
Front Immunol; 2022; 13():896654. PubMed ID: 35707542
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
16. Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
Li S; Wang L; Zhang M; Zhou W; Fang W; Wang Q; Qi C; Mou S; Shao X; Ni Z
Nephron; 2017; 135(2):87-96. PubMed ID: 27974710
[TBL] [Abstract][Full Text] [Related]
17. Complete Remission in the Nephrotic Syndrome Study Network.
Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
[TBL] [Abstract][Full Text] [Related]
18. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
[TBL] [Abstract][Full Text] [Related]
20. Nephrotic syndrome and idiopathic membranous nephropathy associated with autosomal-dominant polycystic kidney disease.
Peces R; Martínez-Ara J; Peces C; Picazo M; Cuesta-López E; Vega C; Azorín S; Selgas R
ScientificWorldJournal; 2011 May; 11():1041-7. PubMed ID: 21552769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
